Introduction of Subcutaneous Infliximab CT-P13 and Vedolizumab in Clinical Practice: A Multi-Stakeholder Position Statement Highlighting the Need for Post-Marketing Studies (vol 16, pg 1059, 2022)
Published in 2023 by
Liselotte Fierens 
,
Claire Liefferinckx,
Eveline Hoefkens,
Triana Lobaton,
Erwin Dreesen,
João Sabino,
Marc Ferrante
,
Claire Liefferinckx,
Eveline Hoefkens,
Triana Lobaton,
Erwin Dreesen,
João Sabino,
Marc Ferrante
